OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
Abstract. A new role of B-cells in pathogenesis of multiple sclerosis (MS), their relations with B-cells indevelopment of inflammation and probable mechanisms of advanced therapeutic intervention in order to reach B-cell depletion are subject to discussion in present article. Here we describe a clin...
Saved in:
| Main Authors: | E. P. Evdoshenko, A. L. Maslyancky, L. G. Zaslavsky, A. A. Skoromets, I. S. Ziuzgin, O. E. Riabykina, N. A. Totolian, E. E. Zueva, S. V. Lapin, Areg A. Totolian |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2014-07-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/144 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS
by: V. D. Nazarov, et al.
Published: (2015-06-01) -
Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs
by: Guilherme Diogo Silva, et al.
Published: (2025-09-01) -
The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2023-08-01) -
Efficacy of rituximab in secondary progressive multiple sclerosis: Insights from magnetic resonance imaging and disability assessments
by: Fereshteh Ashtari, et al.
Published: (2025-07-01) -
Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis
by: A. N. Boyko, et al.
Published: (2019-11-01)